These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

686 related articles for article (PubMed ID: 28550093)

  • 1. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.
    Song C; Burgess S; Eicher JD; O'Donnell CJ; Johnson AD
    J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28550093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Causal Pathway From Telomere Length to Coronary Heart Disease: A Network Mendelian Randomization Study.
    Zhan Y; Karlsson IK; Karlsson R; Tillander A; Reynolds CA; Pedersen NL; Hägg S
    Circ Res; 2017 Jul; 121(3):214-219. PubMed ID: 28515044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring the causal pathway from omega-6 levels to coronary heart disease: A network Mendelian randomization study.
    Liao LZ; Li WD; Liu Y; Li JP; Zhuang XD; Liao XX
    Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):233-240. PubMed ID: 31648883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic Association of Waist-to-Hip Ratio With Cardiometabolic Traits, Type 2 Diabetes, and Coronary Heart Disease.
    Emdin CA; Khera AV; Natarajan P; Klarin D; Zekavat SM; Hsiao AJ; Kathiresan S
    JAMA; 2017 Feb; 317(6):626-634. PubMed ID: 28196256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis.
    Holmes MV; Lange LA; Palmer T; Lanktree MB; North KE; Almoguera B; Buxbaum S; Chandrupatla HR; Elbers CC; Guo Y; Hoogeveen RC; Li J; Li YR; Swerdlow DI; Cushman M; Price TS; Curtis SP; Fornage M; Hakonarson H; Patel SR; Redline S; Siscovick DS; Tsai MY; Wilson JG; van der Schouw YT; FitzGerald GA; Hingorani AD; Casas JP; de Bakker PI; Rich SS; Schadt EE; Asselbergs FW; Reiner AP; Keating BJ
    Am J Hum Genet; 2014 Feb; 94(2):198-208. PubMed ID: 24462370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood lipid levels mediating the effects of sex hormone-binding globulin on coronary heart disease: Mendelian randomization and mediation analysis.
    Yang J; Zhou J; Liu H; Hao J; Hu S; Zhang P; Wu H; Gao Y; Tang W
    Sci Rep; 2024 May; 14(1):11993. PubMed ID: 38796576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mendelian randomization to assess causal effects of blood lipids on coronary heart disease: lessons from the past and applications to the future.
    Burgess S; Harshfield E
    Curr Opin Endocrinol Diabetes Obes; 2016 Apr; 23(2):124-30. PubMed ID: 26910273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease.
    Ward-Caviness CK; de Vries PS; Wiggins KL; Huffman JE; Yanek LR; Bielak LF; Giulianini F; Guo X; Kleber ME; Kacprowski T; Groß S; Petersman A; Davey Smith G; Hartwig FP; Bowden J; Hemani G; Müller-Nuraysid M; Strauch K; Koenig W; Waldenberger M; Meitinger T; Pankratz N; Boerwinkle E; Tang W; Fu YP; Johnson AD; Song C; de Maat MPM; Uitterlinden AG; Franco OH; Brody JA; McKnight B; Chen YI; Psaty BM; Mathias RA; Becker DM; Peyser PA; Smith JA; Bielinski SJ; Ridker PM; Taylor KD; Yao J; Tracy R; Delgado G; Trompet S; Sattar N; Jukema JW; Becker LC; Kardia SLR; Rotter JI; März W; Dörr M; Chasman DI; Dehghan A; O'Donnell CJ; Smith NL; Peters A; Morrison AC
    PLoS One; 2019; 14(5):e0216222. PubMed ID: 31075152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of depressive mood to plasminogen activator inhibitor, tissue plasminogen activator, and fibrinogen levels in patients with versus without coronary heart disease.
    Lahlou-Laforet K; Alhenc-Gelas M; Pornin M; Bydlowski S; Seigneur E; Benetos A; Kierzin JM; Scarabin PY; Ducimetiere P; Aiach M; Guize L; Consoli SM
    Am J Cardiol; 2006 May; 97(9):1287-91. PubMed ID: 16635597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between plasminogen activator inhibitor type 1 (PAI-1) levels, PAI-1 4G/5G polymorphism, and myocardial infarction: a Mendelian randomization meta-analysis.
    Nikolopoulos GK; Bagos PG; Tsangaris I; Tsiara CG; Kopterides P; Vaiopoulos A; Kapsimali V; Bonovas S; Tsantes AE
    Clin Chem Lab Med; 2014 Jul; 52(7):937-50. PubMed ID: 24695040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis.
    Dale CE; Fatemifar G; Palmer TM; White J; Prieto-Merino D; Zabaneh D; Engmann JEL; Shah T; Wong A; Warren HR; McLachlan S; Trompet S; Moldovan M; Morris RW; Sofat R; Kumari M; Hyppönen E; Jefferis BJ; Gaunt TR; Ben-Shlomo Y; Zhou A; Gentry-Maharaj A; Ryan A; ; Mutsert R; Noordam R; Caulfield MJ; Jukema JW; Worrall BB; Munroe PB; Menon U; Power C; Kuh D; Lawlor DA; Humphries SE; Mook-Kanamori DO; Sattar N; Kivimaki M; Price JF; Davey Smith G; Dudbridge F; Hingorani AD; Holmes MV; Casas JP
    Circulation; 2017 Jun; 135(24):2373-2388. PubMed ID: 28500271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diet-Derived Circulating Antioxidants and Risk of Coronary Heart Disease: A Mendelian Randomization Study.
    Luo J; le Cessie S; van Heemst D; Noordam R
    J Am Coll Cardiol; 2021 Jan; 77(1):45-54. PubMed ID: 33413940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific effect of serum urate levels on coronary heart disease and myocardial infarction prevention: A Mendelian randomization study.
    Yang F; Lu Y; Chen S; Wang K; Hu T; Cui H
    Nutr Metab Cardiovasc Dis; 2022 May; 32(5):1266-1274. PubMed ID: 35197211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Association and Potential Mediators between Sarcopenia and Coronary Heart Disease: A Bidirectional Two-Sample, Two-Step Mendelian Randomization Study.
    He J; Huang M; Li N; Zha L; Yuan J
    Nutrients; 2023 Jul; 15(13):. PubMed ID: 37447340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasminogen activator inhibitor-1 gene: selection of tagging single nucleotide polymorphisms and association with coronary heart disease.
    Su S; Chen S; Zhao J; Huang J; Wang X; Chen R; Gu D
    Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):948-54. PubMed ID: 16424345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HDL Cholesterol Metabolism and the Risk of CHD: New Insights from Human Genetics.
    Vitali C; Khetarpal SA; Rader DJ
    Curr Cardiol Rep; 2017 Nov; 19(12):132. PubMed ID: 29103089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis.
    Nüesch E; Dale C; Palmer TM; White J; Keating BJ; van Iperen EP; Goel A; Padmanabhan S; Asselbergs FW; ; Verschuren WM; Wijmenga C; Van der Schouw YT; Onland-Moret NC; Lange LA; Hovingh GK; Sivapalaratnam S; Morris RW; Whincup PH; Wannamethe GS; Gaunt TR; Ebrahim S; Steel L; Nair N; Reiner AP; Kooperberg C; Wilson JF; Bolton JL; McLachlan S; Price JF; Strachan MW; Robertson CM; Kleber ME; Delgado G; März W; Melander O; Dominiczak AF; Farrall M; Watkins H; Leusink M; Maitland-van der Zee AH; de Groot MC; Dudbridge F; Hingorani A; Ben-Shlomo Y; Lawlor DA; ; Amuzu A; Caufield M; Cavadino A; Cooper J; Davies TL; ; Drenos F; Engmann J; Finan C; Giambartolomei C; Hardy R; Humphries SE; Hypponen E; Kivimaki M; Kuh D; Kumari M; Ong K; Plagnol V; Power C; Richards M; Shah S; Shah T; Sofat R; Talmud PJ; Wareham N; Warren H; Whittaker JC; Wong A; Zabaneh D; Davey Smith G; Wells JC; Leon DA; Holmes MV; Casas JP
    Int J Epidemiol; 2016 Dec; 45(6):1927-1937. PubMed ID: 25979724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasminogen activator inhibitor-1 activity in type 2 diabetes: a different relationship with coronary heart disease and diabetic retinopathy.
    Brazionis L; Rowley K; Jenkins A; Itsiopoulos C; O'Dea K
    Arterioscler Thromb Vasc Biol; 2008 Apr; 28(4):786-91. PubMed ID: 18239151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Causal association between placental growth factor and coronary heart disease: a Mendelian randomization study.
    Zuo B; Zhu S; Zhong G; Bu H; Chen H
    Aging (Albany NY); 2023 Oct; 15(19):10117-10132. PubMed ID: 37787982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of Adiponectin in Coronary Heart Disease Risk: A Mendelian Randomization Study.
    Borges MC; Lawlor DA; de Oliveira C; White J; Horta BL; Barros AJ
    Circ Res; 2016 Jul; 119(3):491-9. PubMed ID: 27252388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.